Table 2.
Cox regression.
Multivariate HR for OS |
Multivariate HR for RFS |
|||||
---|---|---|---|---|---|---|
Variable | HR | 95% CI | P | HR | 95% CI | P |
Age at diagnosis | ||||||
<50 | Reference | Reference | ||||
≥50 | 1.03 | 0.54–1.96 | 0.93 | 0.79 | 0.38–1.62 | 0.51 |
ELN | ||||||
Favorable | Reference | Reference | ||||
Intermediate | 2.37 | 1.08–5.19 | 0.03 | 1.58 | 0.69–3.62 | 0.28 |
Leucocytosis at diagnosis | ||||||
<50 G/L | Reference | Reference | ||||
≥50 G/L | 1.01 | 0.49–2.06 | 0.99 | 0.93 | 0.41–2.11 | 0.86 |
Consolidation | ||||||
No allo-SCT | Reference | Reference | ||||
Allo-SCT | 0.32 | 0.13–0.79 | 0.01 | 0.50 | 0.19–1.33 | 0.17 |
Natural killer (NK) maturation profile | ||||||
Hyper/intermediate | Reference | Reference | ||||
Hypomaturation | 4.15 | 1.58–10.87 | 0.004 | 8.23 | 2.51–26.94 | <0.001 |
Multivariate Cox regression models were used to assess the predictive value of NK maturation profile while adjusting for the prognostic factors in the population (age at diagnosis, ELN, leukocytosis, and allo-SCT as a time-dependent covariate).
Allo-SCT, allogeneic stem cell transplantation; CI, confidence interval; RFS, relapse-free survival; ELN, European Leukemia Net genetic classification; HR, hazard ratio; OS, overall survival.